Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 282

1.

Pegylated Interferon Plus Ribavirin in HIV-infected Patients With Recurrent Hepatitis C After Liver Transplantation: A Prospective Cohort Study.

Castells L, Rimola A, Manzardo C, Valdivieso A, Luis Montero J, Barcena R, Abradelo M, Xiol X, Aguilera V, Salcedo M, Rodriguez M, Bernal C, Suarez F, Antela A, Olivares S, Del Campo S, Laguno M, Fernandez JR, de la Rosa G, Agüero F, Perez I, Gonzalez J, Esteban-Mur JI, Miro JM; the FIPSE LT-HIV investigators.

J Hepatol. 2014 Aug 12. pii: S0168-8278(14)00538-8. doi: 10.1016/j.jhep.2014.07.034. [Epub ahead of print]

PMID:
25127748
[PubMed - as supplied by publisher]
2.

Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study.

Millán O, Rafael-Valdivia L, San Segundo D, Boix F, Castro-Panete MJ, López-Hoyos M, Muro M, Valero-Hervás D, Rimola A, Navasa M, Muñoz P, Miras M, Andrés A, Guirado L, Pascual J, Brunet M.

Clin Immunol. 2014 Oct;154(2):141-54. doi: 10.1016/j.clim.2014.07.007. Epub 2014 Aug 1.

PMID:
25088788
[PubMed - in process]
3.

[Early detection, prevention and management of renal failure in liver transplantation].

Castells L, Baliellas C, Bilbao I, Cantarell C, Cruzado JM, Esforzado N, García-Valdecasas JC, Lladó L, Rimola A, Serón D, Oppenheimer F.

Gastroenterol Hepatol. 2014 Oct;37(8):480-91. doi: 10.1016/j.gastrohep.2013.11.006. Epub 2014 Jul 22. Spanish.

PMID:
25060591
[PubMed - in process]
4.

HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans.

Bohne F, Londoño MC, Benítez C, Miquel R, Martínez-Llordella M, Russo C, Ortiz C, Bonaccorsi-Riani E, Brander C, Bauer T, Protzer U, Jaeckel E, Taubert R, Forns X, Navasa M, Berenguer M, Rimola A, Lozano JJ, Sánchez-Fueyo A.

Sci Transl Med. 2014 Jun 25;6(242):242ra81. doi: 10.1126/scitranslmed.3008793.

PMID:
24964989
[PubMed - in process]
5.

Somatostatin therapy protects porcine livers in small-for-size liver transplantation.

Hessheimer AJ, Escobar B, Muñoz J, Flores E, Gracia-Sancho J, Taurá P, Fuster J, Rimola A, García-Valdecasas JC, Fondevila C.

Am J Transplant. 2014 Aug;14(8):1806-16. doi: 10.1111/ajt.12758. Epub 2014 Jun 16.

PMID:
24935350
[PubMed - in process]
6.

Interstellar H adsorption and H₂ formation on the crystalline (010) forsterite surface: a B3LYP-D2* periodic study.

Navarro-Ruiz J, Sodupe M, Ugliengo P, Rimola A.

Phys Chem Chem Phys. 2014 Sep 7;16(33):17447-57. doi: 10.1039/c4cp00819g.

PMID:
24781059
[PubMed - in process]
7.

The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.

Roman A, Manito N, Campistol JM, Cuervas-Mons V, Almenar L, Arias M, Casafont F, del Castillo D, Crespo-Leiro MG, Delgado JF, Herrero JI, Jara P, Morales JM, Navarro M, Oppenheimer F, Prieto M, Pulpón LA, Rimola A, Serón D, Ussetti P; ATOS working group.

Transplant Rev (Orlando). 2014 Apr;28(2):84-91. doi: 10.1016/j.trre.2014.01.001. Epub 2014 Jan 27.

PMID:
24602805
[PubMed - in process]
8.

B3LYP Periodic Study of the Physicochemical Properties of the Nonpolar (010) Mg-Pure and Fe-Containing Olivine Surfaces.

Navarro-Ruiz J, Ugliengo P, Rimola A, Sodupe M.

J Phys Chem A. 2014 Aug 7;118(31):5866-75. doi: 10.1021/jp4118198. Epub 2014 Feb 19.

PMID:
24517343
[PubMed - in process]
9.

Silent information regulator 1 protects the liver against ischemia-reperfusion injury: implications in steatotic liver ischemic preconditioning.

Pantazi E, Zaouali MA, Bejaoui M, Serafin A, Folch-Puy E, Petegnief V, De Vera N, Ben Abdennebi H, Rimola A, Roselló-Catafau J.

Transpl Int. 2014 May;27(5):493-503. doi: 10.1111/tri.12276. Epub 2014 Mar 5.

PMID:
24472096
[PubMed - in process]
10.

Formation of hydroxyacetonitrile (HOCH2CN) and polyoxymethylene (POM)-derivatives in comets from formaldehyde (CH2O) and hydrogen cyanide (HCN) activated by water.

Danger G, Rimola A, Abou Mrad N, Duvernay F, Roussin G, Theule P, Chiavassa T.

Phys Chem Chem Phys. 2014 Feb 28;16(8):3360-70. doi: 10.1039/c3cp54034k.

PMID:
24202268
[PubMed - in process]
11.

Bortezomib enhances fatty liver preservation in Institut George Lopez-1 solution through adenosine monophosphate activated protein kinase and Akt/mTOR pathways.

Bejaoui M, Zaouali MA, Folch-Puy E, Pantazi E, Bardag-Gorce F, Carbonell T, Oliva J, Rimola A, Abdennebi HB, Roselló-Catafau J.

J Pharm Pharmacol. 2014 Jan;66(1):62-72. doi: 10.1111/jphp.12154. Epub 2013 Oct 16.

PMID:
24127984
[PubMed - indexed for MEDLINE]
12.

Physisorption vs. chemisorption of probe molecules on boron nitride nanomaterials: the effect of surface curvature.

Rimola A, Sodupe M.

Phys Chem Chem Phys. 2013 Aug 21;15(31):13190-8. doi: 10.1039/c3cp51728d.

PMID:
23824299
[PubMed]
13.

Insights on the binding of Thioflavin derivative markers to amyloid-like fibril models from quantum chemical calculations.

Alí-Torres J, Rimola A, Rodríguez-Rodríguez C, Rodríguez-Santiago L, Sodupe M.

J Phys Chem B. 2013 Jun 6;117(22):6674-80. doi: 10.1021/jp402807g. Epub 2013 May 28.

PMID:
23662608
[PubMed - indexed for MEDLINE]
14.

Immunosuppression minimization vs. complete drug withdrawal in liver transplantation.

Londoño MC, Rimola A, O'Grady J, Sanchez-Fueyo A.

J Hepatol. 2013 Oct;59(4):872-9. doi: 10.1016/j.jhep.2013.04.003. Epub 2013 Apr 8. Review.

PMID:
23578883
[PubMed - indexed for MEDLINE]
Free Article
15.

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.

Benítez C, Londoño MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, Martínez-Llordella M, López M, Angelico R, Bohne F, Sese P, Daoud F, Larcier P, Roelen DL, Claas F, Whitehouse G, Lerut J, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A.

Hepatology. 2013 Nov;58(5):1824-35. doi: 10.1002/hep.26426. Epub 2013 Sep 19.

PMID:
23532679
[PubMed - indexed for MEDLINE]
16.

Prospective evaluation of single-operator peroral cholangioscopy in liver transplant recipients requiring an evaluation of the biliary tract.

Balderramo D, Sendino O, Miquel R, de Miguel CR, Bordas JM, Martinez-Palli G, Leoz ML, Rimola A, Navasa M, Llach J, Cardenas A.

Liver Transpl. 2013 Feb;19(2):199-206. doi: 10.1002/lt.23585.

PMID:
23404861
[PubMed - indexed for MEDLINE]
17.

Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury.

Zaouali MA, Bardag-Gorce F, Carbonell T, Oliva J, Pantazi E, Bejaoui M, Ben Abdennebi H, Rimola A, Roselló-Catafau J.

Exp Mol Pathol. 2013 Apr;94(2):352-9. doi: 10.1016/j.yexmp.2012.12.005. Epub 2013 Jan 7.

PMID:
23305864
[PubMed - indexed for MEDLINE]
18.

Silica surface features and their role in the adsorption of biomolecules: computational modeling and experiments.

Rimola A, Costa D, Sodupe M, Lambert JF, Ugliengo P.

Chem Rev. 2013 Jun 12;113(6):4216-313. Review. No abstract available.

PMID:
23289428
[PubMed - indexed for MEDLINE]
19.

Intracellular IFN-γ and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients.

Millán O, Rafael-Valdivia L, Torrademé E, López A, Fortuna V, Sánchez-Cabus S, López-Púa Y, Rimola A, Brunet M.

Cytokine. 2013 Feb;61(2):556-64. doi: 10.1016/j.cyto.2012.10.026. Epub 2012 Dec 21.

PMID:
23265966
[PubMed - indexed for MEDLINE]
20.

[The biliary complications in live donor liver transplant do not affect the long-term results].

Sánchez Cabús S, Calatayud D, García-Roca R, Ferrer J, Martí J, Navasa M, Rimola A, Fondevila C, Fuster J, García-Valdecasas JC.

Cir Esp. 2013 Jan;91(1):17-24. doi: 10.1016/j.ciresp.2012.07.012. Epub 2012 Oct 5. Spanish.

PMID:
23044253
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk